Related Experiment Video
Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Evaluating Insulin Delivery Systems Using Dynamic Glucose Region Plots and Risk Space Analysis
Klavs W Hansen1,2, Mia Christensen2, Sanne Fisker3
1Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, 8200 Aarhus, Denmark.
Automated insulin delivery systems were compared using glucose rate of change and glucose levels. System A demonstrated a higher percentage of glucose values expected to remain in the target range compared to System B.
Area of Science:
- Endocrinology
- Biomedical Engineering
- Diabetes Technology
Background:
- Continuous glucose monitoring (CGM) provides valuable data for managing diabetes.
- Automated insulin delivery (AID) systems aim to improve glycemic control.
- Assessing the performance of different AID systems is crucial for patient care.
Purpose of the Study:
- To compare the performance of two AID systems (A and B) using dynamic glucose region plots.
- To evaluate glucose homeostasis by analyzing glucose rate of change (RoC) and glucose levels.
- To identify clinically relevant differences in glycemic control between AID systems.
Main Methods:
- Utilized 60-day CGM data from individuals with type 1 diabetes using AID systems A (n=65) and B (n=85).
- Employed dynamic glucose region plots to visualize simultaneous glucose and RoC values.
- Defined risk spaces to predict glucose trajectory (staying in, leaving, or returning to target range) within 30 minutes.
Main Results:
- System A showed a significantly higher fraction of (RoC, glucose) values predicted to remain in the target range (62.5% vs. 56.8%, p=0.002).
- System A exhibited a slightly lower fraction of values in range with a risk of progressing to hyperglycemia (glucose > 10.0 mmol/L).
- Dynamic glucose region plots effectively demonstrated differences in glucose homeostasis between the two AID systems.
Conclusions:
- Dynamic glucose region plots and risk spaces offer novel insights into glucose homeostasis.
- These methods can reveal clinically significant performance differences between AID systems.
- System A demonstrated superior performance in maintaining glucose within the target range compared to System B.
Related Concept Videos
Oral Hypoglycemic Agents: Glinides
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hypoglycemia and Glucagon

